Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 49 min ago
Peer-reviewedCC BY-NC-NDBMC surgery

Routine versus postoperative CRP/CT guided selective diverting ileostomy after laparoscopic low anterior resection for rectal cancer: a comparative randomized controlled trial.

5 affiliations
  1. 1Colorectal Surgery Unit, Surgery Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  2. 2Surgical Oncology Unit, Surgery Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt. [email protected].
  3. 3Surgery Department, New Borg Al Arab Hospital, Directorate of Health Affairs in Alexandria, Ministry of Health and Population, New Borg El Arab, Egypt. [email protected].
  4. 4Upper GIT and Liver Surgery Unit A, Surgery Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  5. 5Surgery Department, Faculty of Medicine, Portsaid University, Portsaid, Egypt.

Abstract

Background

Diverting ileostomy is routinely used to protect the anastomosis after laparoscopic low anterior resection (LAR) for rectal cancer, but it exposes most patients to stoma-related morbidity even though only a minority develop a true anastomotic leak. This trial evaluated whether a postoperative C-reactive protein (CRP) and computed tomography (CT) guided selective ileostomy strategy could reduce the rate of ileostomy formation compared with routine diversion.Methods

In this RCT, 200 patients with stage II or III middle or lower third rectal cancer undergoing laparoscopic LAR were randomized 1:1 to a CRP/CT-guided selective ileostomy group (n = 100) or a routine diverting ileostomy group (n = 100). In the CRP/CT group, serum CRP was measured daily from postoperative day 1; a threshold of 114 mg/L on day 3 or a rise greater than 15 mg/L per day triggered confirmatory contrast-enhanced CT, with ileostomy formed only if findings were suspicious for leak. The primary outcome was the stoma-free status throughout the 12-month follow-up.Results

Baseline demographic and tumor characteristics were similar between groups (all p > 0.05). Ileostomy formation was markedly lower in the CRP/CT group than the routine group (22.0% vs. 100.0%, p < 0.001). Anastomotic leak rates did not differ (0% vs. 1.0%, p = 1.000), nor did overall complication rates (31.0% vs. 32.0%, p = 0.879). Operative time (148.4 ± 14.0 vs. 166.6 ± 13.1 min, p < 0.001) and intraoperative blood loss (168.9 ± 28.2 vs. 197.3 ± 39.7 mL, p < 0.001) were significantly lower in the CRP/CT group. Stoma-related complications were far less frequent with the selective strategy (3.0% vs. 30.0%, p < 0.001). The CRP/CT group reported significantly better global health status, physical functioning, and emotional functioning scores (all p < 0.001).Conclusion

A postoperative CRP/CT-guided selective ileostomy strategy reduces the need for diverting ileostomy after laparoscopic low anterior resection for rectal cancer while improving operative outcomes and quality of life; however, confirmed leakage was infrequent in both groups. This approach may serve as an alternative to routine diversion in appropriately monitored surgical units.Trial registration

This trial was retrospectively registered at ClinicalTrials.gov (Identifier: NCT07722533) on July 17, 2026.

Related

  1. A Prospective Comparative Study of Opioid-Free Anesthesia and Opioid-Based Anesthesia for Postoperative Pain Relief in Patients Undergoing Laparoscopic Surgeries: A Double-Blinded Randomized Controlled Trial.
    Sneha A Johnson, Dilip Kumar Govindan, Easwar Elango +4
    CureusPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCPMC
  2. PC6 injection enhanced the preventive effect against postoperative nausea of granisetron compared with intravenous injection in gynecological laparoscopic patients: a randomized controlled study
    Jianying Song, Jia Tang, Juan Gu +2
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaCrossrefDOAJ
  3. Perioperative transcutaneous auricular vagus nerve stimulation for the prevention of postoperative nausea and vomiting after gynecologic laparoscopic surgery: protocol for a randomized, double-blind, sham-controlled trial
    R. Wang, H. Yang, H. Li +5
    medRxivPreprintCC BYFull textSurgery & anaesthesiamedRxiv
  4. The effect of goal-directed fluid therapy on endothelial glycocalyx and short-term postoperative recovery quality in older patients undergoing laparoscopic hernia or gallbladder surgery: a randomized controlled double-blind clinical study.
    Qinxian Wei, Man Zhou, Wenji Xu +3
    Frontiers in medicinePeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCPMC
  5. Bilateral Erector Spinae Plane Block With 0.375% Ropivacaine and Postoperative Analgesia After Laparoscopic Cholecystectomy: A Prospective, Randomized, Controlled Cohort Study.
    Kenny Omar Contreras Becerra, Jesus Alberto Sanson-Riofrio, Juan Manuel Lopez Diaz +4
    CureusPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCPMC
BibTeX
@article{moaz2026routine,
  title = {{Routine versus postoperative CRP/CT guided selective diverting ileostomy after laparoscopic low anterior resection for rectal cancer: a comparative randomized controlled trial.}},
  author = {Ahmed M Moaz and Khaled E Barakat and Walid Elshazly and Yasser Zaki and Amr Badawy and Bassem Kh Hegazy and Ahmed M Mohieldein},
  journal = {BMC surgery},
  year = {2026},
  month = oct,
  doi = {10.1186/s12893-026-04248-6},
  url = {https://europepmc.org/article/MED/42875765},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Routine versus postoperative CRP/CT guided selective diverting ileostomy after laparoscopic low anterior resection for rectal cancer: a comparative randomized controlled trial.
AU  - Ahmed M Moaz
AU  - Khaled E Barakat
AU  - Walid Elshazly
AU  - Yasser Zaki
AU  - Amr Badawy
AU  - Bassem Kh Hegazy
AU  - Ahmed M Mohieldein
PY  - 2026
DA  - 2026/10/14
JO  - BMC surgery
DO  - 10.1186/s12893-026-04248-6
UR  - https://europepmc.org/article/MED/42875765
AB  - Background  Diverting ileostomy is routinely used to protect the anastomosis after laparoscopic low anterior resection (LAR) for rectal cancer, but it exposes most patients to stoma-related morbidity even though only a minority develop a true anastomotic leak. This trial evaluated whether a postoperative C-reactive protein (CRP) and computed tomography (CT) guided selective ileostomy strategy could reduce the rate of ileostomy formation compared with routine diversion.Methods  In this RCT, 200 patients with stage II or III middle or lower third rectal cancer undergoing laparoscopic LAR were randomized 1:1 to a CRP/CT-guided selective ileostomy group (n = 100) or a routine diverting ileostomy group (n = 100). In the CRP/CT group, serum CRP was measured daily from postoperative day 1; a threshold of 114 mg/L on day 3 or a rise greater than 15 mg/L per day triggered confirmatory contrast-enhanced CT, with ileostomy formed only if findings were suspicious for leak. The primary outcome was the stoma-free status throughout the 12-month follow-up.Results  Baseline demographic and tumor characteristics were similar between groups (all p > 0.05). Ileostomy formation was markedly lower in the CRP/CT group than the routine group (22.0% vs. 100.0%, p < 0.001). Anastomotic leak rates did not differ (0% vs. 1.0%, p = 1.000), nor did overall complication rates (31.0% vs. 32.0%, p = 0.879). Operative time (148.4 ± 14.0 vs. 166.6 ± 13.1 min, p < 0.001) and intraoperative blood loss (168.9 ± 28.2 vs. 197.3 ± 39.7 mL, p < 0.001) were significantly lower in the CRP/CT group. Stoma-related complications were far less frequent with the selective strategy (3.0% vs. 30.0%, p < 0.001). The CRP/CT group reported significantly better global health status, physical functioning, and emotional functioning scores (all p < 0.001).Conclusion  A postoperative CRP/CT-guided selective ileostomy strategy reduces the need for diverting ileostomy after laparoscopic low anterior resection for rectal cancer while improving operative outcomes and quality of life; however, confirmed leakage was infrequent in both groups. This approach may serve as an alternative to routine diversion in appropriately monitored surgical units.Trial registration  This trial was retrospectively registered at ClinicalTrials.gov (Identifier: NCT07722533) on July 17, 2026.
SN  - 1471-2482
ER  -